b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">29352327</PMID>\n        <DateCompleted>\n            <Year>2018</Year>\n            <Month>05</Month>\n            <Day>29</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2018</Year>\n            <Month>11</Month>\n            <Day>13</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1432-2307</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>472</Volume>\n                    <Issue>5</Issue>\n                    <PubDate>\n                        <Year>2018</Year>\n                        <Month>May</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Virchows Archiv : an international journal of pathology</Title>\n                <ISOAbbreviation>Virchows Arch.</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>LIMK/cofilin pathway and Slingshot are implicated in human colorectal cancer progression and chemoresistance.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>727-737</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s00428-018-2298-0</ELocationID>\n            <Abstract>\n                <AbstractText>Cofilin phospho-regulation is important for actin filament turnover and is implicated in cancer. Phosphorylation of cofilin is mediated by LIM kinases (LIMKs) and dephosphorylation by Slingshot phosphatases (SSH). LIMKs and SSH promote cancer cell invasion and metastasis and represent novel anti-cancer targets. However, little is known regarding LIMK/cofilin and SSH in human colorectal cancer (CRC). In this study, we aimed to address their expression and significance in human CRC. We evaluated expression of non-phosphorylated (active) and phosphorylated cofilin, LIMK1, LIMK2, and SSH1 by immunohistochemistry in 143 human CRC samples in relation to clinicopathologic parameters, response of metastatic disease to chemotherapy, and epithelial-mesenchymal transition (EMT) markers \xce\xb2-catenin, E-cadherin, and ZEB. We show that active cofilin, LIMK1, LIMK2, and SSH1 are overexpressed in human CRC and are associated with tumor progression parameters. SSH1 is an independent predictor of lymph node metastasis by multivariate analysis. LIMK1 and SSH1 expression is also higher in non-responders to chemotherapy, and SSH1 is shown by multivariate analysis to independently predict response of metastatic disease to chemotherapy. Active cofilin, LIMK1, LIMK2, and SSH1 also correlated with the EMT markers examined. In addition, immunofluorescence analysis showed increased expression of active cofilin, LIMK1, LIMK2, and SSH1 in HT29 colon cancer cells resistant to 5-fluorouracil compared to parental HT29 cells. Our results suggest that F-actin regulators LIMK/cofilin pathway and SSH1 are associated with CRC progression and chemoresistance representing promising tumor biomarkers and therapeutic targets in CRC.</AbstractText>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Aggelou</LastName>\n                    <ForeName>Helen</ForeName>\n                    <Initials>H</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Anatomy-Histology-Embryology, Medical School, University of Patras, 26500, Patras, Greece.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Chadla</LastName>\n                    <ForeName>Panagiota</ForeName>\n                    <Initials>P</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Anatomy-Histology-Embryology, Medical School, University of Patras, 26500, Patras, Greece.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Nikou</LastName>\n                    <ForeName>Sofia</ForeName>\n                    <Initials>S</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Anatomy-Histology-Embryology, Medical School, University of Patras, 26500, Patras, Greece.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Karteri</LastName>\n                    <ForeName>Sofia</ForeName>\n                    <Initials>S</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Anatomy-Histology-Embryology, Medical School, University of Patras, 26500, Patras, Greece.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Maroulis</LastName>\n                    <ForeName>Ioannis</ForeName>\n                    <Initials>I</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Surgery, University of Patras Medical School, Patras, Greece.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Kalofonos</LastName>\n                    <ForeName>Haralabos P</ForeName>\n                    <Initials>HP</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Oncology, University of Patras Medical School, Patras, Greece.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Papadaki</LastName>\n                    <ForeName>Helen</ForeName>\n                    <Initials>H</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Anatomy-Histology-Embryology, Medical School, University of Patras, 26500, Patras, Greece.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Bravou</LastName>\n                    <ForeName>Vasiliki</ForeName>\n                    <Initials>V</Initials>\n                    <Identifier Source="ORCID">http://orcid.org/0000-0002-4635-0204</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Anatomy-Histology-Embryology, Medical School, University of Patras, 26500, Patras, Greece. vibra@upatras.gr.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2018</Year>\n                <Month>01</Month>\n                <Day>19</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>Germany</Country>\n            <MedlineTA>Virchows Arch</MedlineTA>\n            <NlmUniqueID>9423843</NlmUniqueID>\n            <ISSNLinking>0945-6317</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D051339">Actin Depolymerizing Factors</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D014408">Biomarkers, Tumor</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>EC 2.7.11.1</RegistryNumber>\n                <NameOfSubstance UI="C515892">LIMK1 protein, human</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>EC 2.7.11.1</RegistryNumber>\n                <NameOfSubstance UI="C102895">LIMK2 protein, human</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>EC 2.7.11.1</RegistryNumber>\n                <NameOfSubstance UI="D054461">Lim Kinases</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>EC 3.1.3.16</RegistryNumber>\n                <NameOfSubstance UI="D010749">Phosphoprotein Phosphatases</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>EC 3.1.3.16</RegistryNumber>\n                <NameOfSubstance UI="C484329">SSH1 protein, human</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D051339" MajorTopicYN="N">Actin Depolymerizing Factors</DescriptorName>\n                <QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>\n                <QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000971" MajorTopicYN="N">Antineoplastic Combined Chemotherapy Protocols</DescriptorName>\n                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D014408" MajorTopicYN="N">Biomarkers, Tumor</DescriptorName>\n                <QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D015179" MajorTopicYN="N">Colorectal Neoplasms</DescriptorName>\n                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>\n                <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D019008" MajorTopicYN="N">Drug Resistance, Neoplasm</DescriptorName>\n                <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D054461" MajorTopicYN="N">Lim Kinases</DescriptorName>\n                <QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>\n                <QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D010749" MajorTopicYN="N">Phosphoprotein Phosphatases</DescriptorName>\n                <QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>\n                <QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>\n                <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">Chemoresistance</Keyword>\n            <Keyword MajorTopicYN="N">Cofilin</Keyword>\n            <Keyword MajorTopicYN="N">Colorectal cancer</Keyword>\n            <Keyword MajorTopicYN="N">EMT</Keyword>\n            <Keyword MajorTopicYN="N">LIMK</Keyword>\n            <Keyword MajorTopicYN="N">Slingshot</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2017</Year>\n                <Month>10</Month>\n                <Day>18</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2018</Year>\n                <Month>01</Month>\n                <Day>10</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="revised">\n                <Year>2017</Year>\n                <Month>12</Month>\n                <Day>15</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2018</Year>\n                <Month>1</Month>\n                <Day>21</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2018</Year>\n                <Month>5</Month>\n                <Day>31</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2018</Year>\n                <Month>1</Month>\n                <Day>21</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">29352327</ArticleId>\n            <ArticleId IdType="doi">10.1007/s00428-018-2298-0</ArticleId>\n            <ArticleId IdType="pii">10.1007/s00428-018-2298-0</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Reference>\n                <Citation>Eur J Histochem. 2010 Apr 13;54(2):e14</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20558337</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Gene Med. 2004 Mar;6(3):357-63</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15026997</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncogene. 2010 Aug 26;29(34):4741-51</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20531305</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Cancer. 2007 Nov 15;121(10):2162-71</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17583572</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Hum Pathol. 2011 Apr;42(4):516-21</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21237490</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>PLoS One. 2011;6(11):e27309</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22087286</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Proc Natl Acad Sci U S A. 2003 Jun 10;100(12):7247-52</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12777619</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Lett. 2015 May 1;360(2):171-6</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25684665</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Science. 2015 Jan 23;347(6220):1260419</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25613900</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Zebrafish. 2009 Dec;6(4):433-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20047470</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Sci Rep. 2017 Mar 30;7:45624</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28358024</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncotarget. 2017 Aug 3;8(39):66195-66203</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29029503</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mol Cancer. 2007 Jun 08;6:40</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17559677</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Curr Opin Cell Biol. 2006 Feb;18(1):26-31</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16337782</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Pharmacol Res. 2017 May;119:422-430</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28274853</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncotarget. 2016 Aug 9;7(32):50816-50817</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27463010</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncol Lett. 2015 Jun;9(6):2757-2761</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26137141</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nature. 1998 Jun 25;393(6687):805-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">9655397</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Res. 2016 Jun 15;76(12 ):3541-52</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27216191</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cell Signal. 2013 Feb;25(2):457-69</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23153585</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Res. 2012 Sep 1;72(17):4429-39</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22761334</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cell. 2002 Jan 25;108(2):233-46</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">11832213</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Pathol. 2006 Jan;208(1):91-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16278819</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Tumour Biol. 2014 Feb;35(2):1233-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24018823</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Cell Sci. 2012 Mar 1;125(Pt 5):1204-16</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22492986</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Biol Chem. 2003 Sep 19;278(38):36868-75</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12821664</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Gastrointest Surg. 2016 Mar;20(3):568-79</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26408331</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Proteome Res. 2007 Feb;6(2):772-80</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17269733</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Biol Chem. 2008 Mar 7;283(10 ):6013-21</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18171679</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Trends Cell Biol. 2002 Dec;12(12):598-605</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12495849</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncotarget. 2016 Mar 1;7(9):10498-512</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26871290</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncotarget. 2015 Nov 17;6(36):38469-86</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26540348</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Biochim Biophys Acta. 2007 May;1773(5):642-52</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16926057</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Gut. 2014 Mar;63(3):480-93</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23585469</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Physiol Rev. 2003 Apr;83(2):433-73</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12663865</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Toxicol Res. 2015 Jun;31(2):151-6</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26191381</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncotarget. 2017 Jun 20;8(25):41749-41763</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28445157</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Res. 2009 Mar 1;69(5):1951-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19244128</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncol Res. 2013;20(11):491-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24063279</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Histochem Cell Biol. 2012 Nov;138(5):725-36</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22790341</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Cell Biol. 2005 Oct 24;171(2):349-59</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16230460</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>PLoS One. 2015 Jul 13;10(7):e0132759</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26167914</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Invest. 2015;33(8):387-97</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26115385</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mol Cancer. 2011 Jun 18;10:75</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21682918</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Mol Sci. 2016 Dec 22;18(1):</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28025492</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer. 2010 Aug 1;116(15):3645-55</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20564088</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncotarget. 2017 Jun 13;8(24):39131-39142</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28388575</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nat Rev Cancer. 2002 Jun;2(6):442-54</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12189386</ArticleId>\n                </ArticleIdList>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'